← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Regenx Biosciences, Llc
Washington, DC
$3,862,729
Total funding
5
Grants
Funding over time
peak $3.1M · FY2010–13$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
Funding mix
By agency
NIH$3,862,729 · 5
By mechanism
RC3$2,822,695 · 1
R43$829,025 · 3
R41$211,009 · 1
Investigators at Regenx Biosciences, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel Adeno-Associated Viral Therapy for X-linked Retinitis Pigmentosa$2,822,695
RC3 · FY2010 · EY
Novel Adeno-Associated Viral Therapy for Wet Age-Related Macular Degeneration$304,421
R43 · FY2012 · EY
Scalable Production of New Generation Adeno-Associated Virus Gene Therapy Vectors$263,277
R43 · FY2010 · DK
Genetically-delivered Bevacizumab for Treatment of Wet Age-Related Macular Degene$261,327
R43 · FY2013 · EY
AAV Mediated Gene Transfer to the CNS for MPS I$211,009
R41 · FY2012 · DK